ArticleAmerican journal of preventive medicine2017

Age-specific Cost Effectiveness of Using Intravenous Recombinant Tissue Plasminogen Activator for Treating Acute Ischemic Stroke.

Heesoo Joo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.